GeneCopoeia ACE2 and lung stable cell lines for COVID-19 research

Thursday, 28 May, 2020 | Supplied by: United Bioresearch Products Pty Ltd



GeneCopoeia offers collections of cell lines expressing human host factors needed for SARS-CoV-2 infection as well as labelled cancer cell lines, which include five lung cancer cell line derivatives.

Angiotensin-converting enzyme 2 (ACE2) has been identified as a functional receptor for SARS-CoV1 and a potent receptor for 2019-nCoV2. ACE2 is a carboxypeptidase that potently degrades angiotensin II to angiotensin 1–7, playing a key role in the renin-angiotensin system (RAS). GeneCopoeia carries a HEK293T cell line expressing ACE2, the receptor needed for SARS-CoV-2 infection in humans.

In addition to the ACE2 stable cell line, the company also offers lung cancer cell lines, which contain both firefly luciferase and GFP or GFP alone, integrated into the genome. These are valuable for COVID-19 coronavirus research since the SARS-CoV-2 virus enters the body via lung epithelial cells, and can be used for drug target identification and compound screening either in vitro or in vivo.

Online: www.unitedbioresearch.com.au
Phone: 02 4575 0309
Related Products

Enzo Life Sciences AMPINEXT DNA Library Preparation Kit (Illumina)

The AMPINEXT DNA Library Preparation Kit (Illumina), from Enzo Life Sciences, is a complete set...

Agilent BenchCel Microplate Handler

The Agilent BenchCel Microplate Handler is a compact microplate storage and automated microplate...

Enzo Life Sciences SARS-CoV-2 IgG ELISA kit

Enzo's ELISA assay is a qualitative assay optimised to provide sensitive detection of IgG...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd